Alterity Therapeutics Ltd.ASX: ATH

FDA Meeting Minutes Confirm Registrational Path for ATH434

Jul 7, 2026 at 12:05 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd. has released a press release.

View Attachment

Earlier from Alterity Therapeutics

Alterity Therapeutics: Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System AtrophyMay 19

All Alterity Therapeutics news releases